US Patent Issued to Island Pharmaceuticals on Nov. 18 for "Methods, compositions, and dosing regimens for treatment of SARS-CoV-2 infections" (Alabama, North Carolina Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,197, issued on Nov. 18, was assigned to Island Pharmaceuticals Ltd. (Melbourne, Australia).

"Methods, compositions, and dosing regimens for treatment of SARS-CoV-2 infections" was invented by Yarlagadda S. Babu (Birmingham, Ala.), Amanda Mathis (Raleigh, N.C.) and William P. Sheridan (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds of the formula I and pharmaceutically acceptable salts, solvates, and hydrates thereof, for use in treating or suppressing a SARS-CoV-2 infection in a subject. A novel dosing regimen for administration of the disclosed compounds is also provided comprising administering at least one load...